{"id":12055,"date":"2021-06-21T09:00:00","date_gmt":"2021-06-21T13:00:00","guid":{"rendered":"https:\/\/wfh.org\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/"},"modified":"2024-04-19T11:23:57","modified_gmt":"2024-04-19T15:23:57","slug":"a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/","title":{"rendered":"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"12055\" class=\"elementor elementor-12055 elementor-2765\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6869d06 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6869d06\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-94337fb\" data-id=\"94337fb\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2a44836 elementor-widget elementor-widget-text-editor\" data-id=\"2a44836\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Le 2 juin 2021, la F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie (FMH) a tenu le webinaire \u00ab\u00a0<a href=\"https:\/\/elearning.wfh.org\/resource\/covid-19-vaccines-and-people-with-bleeding-disorders-safety-and-accessibility\/\" target=\"_blank\" rel=\"noopener noreferrer\">S\u00e9curit\u00e9 et accessibilit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation<\/a>\u00a0\u00bb, qui a abord\u00e9 les pr\u00e9occupations et les besoins de la communaut\u00e9 mondiale des troubles de la coagulation, permettant ainsi d\u2019envisager la vaccination avec plus de s\u00e9r\u00e9nit\u00e9.<\/p>\n<p>Plus de 300 participant\u00b7es de 118 pays diff\u00e9rents ont assist\u00e9 \u00e0 l\u2019\u00e9v\u00e9nement, \u00e9cout\u00e9 les pr\u00e9sentations et particip\u00e9 \u00e0 la session questions-r\u00e9ponses. Ce webinaire a accueilli des intervenant\u00b7es de plusieurs organisations cl\u00e9s qui sont en premi\u00e8re ligne des efforts de vaccination de cette pand\u00e9mie, notamment l\u2019Agence europ\u00e9enne des m\u00e9dicaments (AEM), la Food and Drug Administration (FDA) des \u00c9tats-Unis et l\u2019Organisation mondiale de la sant\u00e9 (OMS). Des expert\u00b7es de la FMH participaient \u00e9galement au panel pour proposer aux participant\u00b7es des recommandations compl\u00e8tes \u00e0 destination des personnes atteintes d\u2019un trouble de la coagulation.<\/p>\n<p>L\u2019\u00e9v\u00e9nement a \u00e9t\u00e9 ouvert par une pr\u00e9sentation du Dr Cedric Hermans (PhD, Belgique), membre m\u00e9dical du conseil d\u2019administration, qui a \u00e9voqu\u00e9 les questions majeures relatives \u00e0 la vaccination contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation. Les deux interventions suivantes \u2013 respectivement de Manuela Mura (PhD, Pays-Bas), responsable scientifique \u00e0 l\u2019Agence europ\u00e9enne des m\u00e9dicaments, et du Dr Peter Marks (PhD, \u00c9tats-Unis), directeur du Center for Biologics Evaluation and Research de la FDA \u2014 se sont pench\u00e9es sur l\u2019autorisation et la s\u00e9curit\u00e9 des vaccins contre la COVID-19, en particulier du point de vue des organismes de r\u00e9glementation de l\u2019Union europ\u00e9enne et des \u00c9tats-Unis. La derni\u00e8re pr\u00e9sentation, celle de Claudia Nannei, responsable technique principale \u00e0 l\u2019OMS (Suisse), a pass\u00e9 en revue les nouvelles informations sur l\u2019initiative COVAX de la Coalition pour les innovations en mati\u00e8re de pr\u00e9paration aux \u00e9pid\u00e9mies (CEPI), de Gavi (l\u2019Alliance du vaccin), et de l\u2019OMS.<\/p>\n<p>\u00ab\u00a0Avec son impressionnant panel d\u2019intervenant\u00b7es repr\u00e9sentant la FDA, l\u2019AEM et le projet COVAX en collaboration avec l\u2019OMS, le webinaire a donn\u00e9 les derni\u00e8res informations sur l\u2019acc\u00e8s mondial aux vaccins contre la COVID. La distribution des vaccins est tr\u00e8s d\u00e9s\u00e9quilibr\u00e9e entre les pays \u00e0 hauts revenus et \u00e0 faibles revenus. Pourtant, si nous ne vaccinons pas tout le monde le plus rapidement possible, nous risquons toutes et tous d\u2019\u00eatre expos\u00e9s \u00e0 des variants de la COVID, qui prolongeront la pand\u00e9mie dans toutes les r\u00e9gions.\u00a0\u00bb<br \/>\n\u2014 Dr Glenn Pierce (PhD), vice-pr\u00e9sident m\u00e9dical de la FMH<\/p>\n<p>Les pr\u00e9sentations ont \u00e9t\u00e9 suivies d\u2019une session de questions-r\u00e9ponses tr\u00e8s dynamiques, qui ont permis d\u2019avoir l\u2019expertise du Dr Glenn Pierce (PhD), vice-pr\u00e9sident m\u00e9dical de la FMH (\u00c9tats-Unis), et de Radoslaw F. Kaczmarek (PhD), pr\u00e9sident du Comit\u00e9 sur la s\u00e9curit\u00e9, l\u2019approvisionnement et l\u2019acc\u00e8s aux m\u00e9dicaments (Pologne\/\u00c9tats-Unis), ainsi que d\u2019autres membres du panel.<\/p>\n<p>Si vous n\u2019avez pas pu assister au webinaire, vous pouvez le r\u00e9\u00e9couter sur la plateforme de formation en ligne de la FMH\u00a0<a href=\"https:\/\/elearning.wfh.org\/resource\/vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation-securite-et-accessibilite\/\" target=\"_blank\" rel=\"noopener noreferrer\">en cliquant ici<\/a>. Vous pourrez \u00e9galement revoir le webinaire du 12 mars 2021 intitul\u00e9 \u00ab\u00a0Traitement et vaccination des personnes atteintes d\u2019un trouble de la coagulation contre la COVID-19\u00a0\u00bb\u00a0<a href=\"https:\/\/elearning.wfh.org\/resource\/vaccination-et-traitement-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\" target=\"_blank\" rel=\"noopener noreferrer\">ici<\/a>. Pour assister aux webinaires organis\u00e9s par la FMH, consultez le calendrier de nos \u00e9v\u00e9nements\u00a0<a href=\"https:\/\/www.wfh.org\/en\/calendar-of-events\">ici<\/a>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Le 2 juin 2021, la F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie (FMH) a tenu le webinaire \u00ab S\u00e9curit\u00e9 et accessibilit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation \u00bb, qui a abord\u00e9 les pr\u00e9occupations et les besoins de la communaut\u00e9 mondiale des troubles de la coagulation, permettant ainsi d\u2019envisager la vaccination avec plus de s\u00e9r\u00e9nit\u00e9.<\/p>\n","protected":false},"author":3,"featured_media":19564,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[178,189],"tags":[],"search-category":[85],"class_list":["post-12055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ateliers-medicaux","category-evenements","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation\" \/>\n<meta property=\"og:description\" content=\"Le 2 juin 2021, la F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie (FMH) a tenu le webinaire \u00ab S\u00e9curit\u00e9 et accessibilit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation \u00bb, qui a abord\u00e9 les pr\u00e9occupations et les besoins de la communaut\u00e9 mondiale des troubles de la coagulation, permettant ainsi d\u2019envisager la vaccination avec plus de s\u00e9r\u00e9nit\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-21T13:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-19T15:23:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Electra Rozakis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Electra Rozakis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\"},\"author\":{\"name\":\"Electra Rozakis\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887\"},\"headline\":\"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation\",\"datePublished\":\"2021-06-21T13:00:00+00:00\",\"dateModified\":\"2024-04-19T15:23:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\"},\"wordCount\":615,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"articleSection\":[\"Ateliers m\u00e9dicaux\",\"\u00c9v\u00e9nements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\",\"name\":\"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"datePublished\":\"2021-06-21T13:00:00+00:00\",\"dateModified\":\"2024-04-19T15:23:57+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887\",\"name\":\"Electra Rozakis\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation","og_description":"Le 2 juin 2021, la F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie (FMH) a tenu le webinaire \u00ab S\u00e9curit\u00e9 et accessibilit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation \u00bb, qui a abord\u00e9 les pr\u00e9occupations et les besoins de la communaut\u00e9 mondiale des troubles de la coagulation, permettant ainsi d\u2019envisager la vaccination avec plus de s\u00e9r\u00e9nit\u00e9.","og_url":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2021-06-21T13:00:00+00:00","article_modified_time":"2024-04-19T15:23:57+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","type":"image\/png"}],"author":"Electra Rozakis","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Electra Rozakis","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/"},"author":{"name":"Electra Rozakis","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887"},"headline":"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation","datePublished":"2021-06-21T13:00:00+00:00","dateModified":"2024-04-19T15:23:57+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/"},"wordCount":615,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","articleSection":["Ateliers m\u00e9dicaux","\u00c9v\u00e9nements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/","url":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/","name":"\u00c0 la FMH, le point de vue de la FDA, de l\u2019AEM et de l\u2019OMS sur la s\u00e9curit\u00e9 des vaccins contre la COVID-19 pour les personnes atteintes d\u2019un trouble de la coagulation | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","datePublished":"2021-06-21T13:00:00+00:00","dateModified":"2024-04-19T15:23:57+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/a-la-fmh-le-point-de-vue-de-la-fda-de-laem-et-de-loms-sur-la-securite-des-vaccins-contre-la-covid-19-pour-les-personnes-atteintes-dun-trouble-de-la-coagulation\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887","name":"Electra Rozakis"}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/12055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=12055"}],"version-history":[{"count":0,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/12055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/19564"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=12055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=12055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=12055"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=12055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}